Business Description
BioAtla is a San Diego-based company focused on developing antibody-based treatments for solid tumor cancers. Its pipeline includes several advanced drug candidates targeting conditions such as lung cancer, melanoma, sarcoma, and colorectal cancer, among others. Founded in 2007, the company builds its treatments around a proprietary technology that allows its drugs to activate selectively within tumor environments, aiming to improve effectiveness while reducing harm to healthy tissue.
